TABLE 5.
Gene | Nuc IDa | HCMV fold changeb | UV-HCMV fold changeb |
---|---|---|---|
2′-5′oligoadenylate synthetase-like | AJ225089 | 57.1, 26.1 | 74.7, 65.1 |
Activating transcription factor 3 (ATF3) | L19871 | 6.5, 8.6 | 47.3, 47.9 |
Acute myeloid leukemia protein | X90976 | −3.4, −4.1 | −3.7, −3.8 |
ADP-ribosylation factor-like 7 | AB016811 | ∼−19.0, ∼−16.2 | −3.3, −3.5 |
Adrenomedullin | D14874 | −11.8, −11.5 | −11, −12.1 |
AML1 mRNA for AML1b protein (alternatively spliced product) | D43968 | −6.1, −11.5 | −3.7, −3.9 |
Apolipoprotein AI regulatory protein (ARP-1) | M64497 | −5.1, −5.6 | −5.5, −5.5 |
B2-bradykinin receptor 3 | X86163 | −8.2, −7.9 | −7.7, −9.1 |
beta-transducin repeat containing protein | Y14153 | ∼5.0, ∼8.9 | ∼5.4, ∼4.6 |
C2f | U72514 | ∼−6.9, −3.7 | −6.3, ∼−12.6 |
cAMP-responsive element modulator | S68271 | 3.8, 4.3 | 5.3, 4.7 |
cdc25 homolog | S78187 | −3.1, −2.3 | −8.3, −4.6 |
Cdc42 effector protein 2 | AF001436 | −3.7, ∼−11.3 | ∼−11.4, ∼−8.8 |
c-fos | V01512 | 11.1, 8.5 | 23, 23.7 |
Chromosome 12 open reading frame | AF052105 | 4.1, 4.5 | 4.4, 4.4 |
Cleavage stimulation factor, 3′ pre-RNA, subunit 1, 50 kDa | L02547 | ∼6.1, −5.4 | ∼−12.7, −7.9 |
Core-binding factor, runt domain, alpha subunit 2; cyclin D-related | D43638 | −6, −6.9 | −3.2, −4 |
Cyclin E2 | AF091433 | 4.6, ∼6.6 | ∼4.7, ∼6.6 |
Cyclin-dependent kinase inhibitor 1B (p27, Kip1) | AI304854 | ∼−16.0, −10.8 | −5.6, −8.4 |
Cyclooxygenase 2 | U04636 | 5.7, 3.9 | 25.6, 23.3 |
DKFZP564B0769 protein | AL080186 | ∼−8.9, ∼−5.7 | ∼−9.0, ∼−6.4 |
DKFZP586K1520 protein | AL050153 | −4.1, −4.5 | ∼−12.4, ∼−13.5 |
DNA sequence from clone 1175I6 on chromosome 20 | AL049538 | −3.2, −3 | −3.1, −3.2 |
Dual-specificity phosphatase 10 | AB026436 | ∼−8.9, ∼−11.9 | ∼−12.6, −3.9 |
EGR alpha | S81439 | −6.5, −3.6 | −3.8, −4.5 |
ESTs | H94842 | −9, −4.6 | −5.5, −7.2 |
Fucose-1-phosphate guanylyltransferase | AF017445 | −3.8, −7.5 | −3.4, −3.1 |
Gamma-interferon-inducible early response gene (homology to platelet proteins) | X02530 | ∼3.0, ∼7.4 | ∼199.1, ∼179.1 |
gas1 | L13698 | −27.1, −37.7 | −24, −19.4 |
Growth differentiation factor 5 (cartilage-derived morphogenetic protein 1) | X80915 | ∼−24.0, ∼−24.0 | ∼−19.6, ∼−25.3 |
GS3955 | D87119 | ∼−19.9, ∼−20.0 | −9.9, −12.6 |
GTP cyclohydrolase 1 (dopa-responsive dystonia) | U19523 | 3.6, ∼7.2 | ∼34.9, ∼29.2 |
homeo box A9 | U41813 | ∼−8.9, ∼−9.2 | ∼−10.9, ∼−11.9 |
Homo sapiens cDNA FLJ13555 fis, clone PLACE1007677 | AL080210 | ∼−7.5, ∼−5.4 | ∼−6.7, ∼−7.0 |
Homo sapiens cDNA, 5′ end | N36638 | −7.3, −8.9 | −6.4, −7.1 |
Homo sapiens cig5 mRNA, partial sequence | AF026941 | ∼12.7, ∼18.9 | ∼326.2, ∼290.8 |
Homo sapiens mRNA; cDNA DKFZp564G103 | AL049268 | ∼−5.7, ∼−5.0 | ∼−6.1, ∼−6.5 |
hSIAH1 | U76247 | −3, −4.1 | −3.4, −3.7 |
hTCF-4 | Y11306 | ∼−22.5, ∼−13.2 | ∼−18.3, ∼−17.2 |
Hypothetical protein | AA522530 | −4.1, −3.6 | −9.8, −3.7 |
Hypothetical protein LOC57187 | AA928996 | ∼−9.5, ∼−6.5 | ∼−4.2, ∼−5.1 |
Hypothetical protein FLB6421 | AI133727 | 6, 5.4 | 9.4, 9 |
Hypothetical protein FLJ10262 | AA115140 | −5.2, −6.3 | −5.7, −5 |
Inhibitor of DNA binding 2, dominant-negative helix-loop-helix protein | D13891 | −3.9, −3 | −10.2, −6.6 |
Interferon-induced protein with tetratricopeptide repeats 4 | AF026939 | 11.3, 8.8 | 8.6, 7.4 |
Interleukin 11 | X58377 | ∼41.1, ∼53.5 | ∼133.9, ∼113.1 |
ISG-54K gene (interferon-stimulated gene) | M14660 | 32.2, 16.7 | 11, 10.6 |
KIAA0112 protein; homolog of yeast ribosome biogenesis regulatory protein RRS1 | D25218 | ∼−8.3, −5.3 | ∼−12.7, ∼−11.4 |
KIAA0671 gene product | AB014571 | −10.1, −8.9 | −10.8, −9.6 |
KIAA1010 protein | AB023227 | −3.4, −6.5 | −11.1, −7.9 |
KIAA1116 protein | AB029039 | −3.9, −3.3 | −4.4, −4.6 |
KIAA1288 protein | AL096842 | ∼−5.9, ∼−3.2 | ∼−7.2, ∼−4.5 |
Monoclonal antibody 21 (Caenorhabditis elegans)-like 1 | U38810 | −13.9, −30.5 | −14.7, −9.7 |
Meis1 (mouse) homolog | U85707 | −5.5, ∼−21.8 | −6.5, −5 |
Mitogen-induced nuclear orphan receptor (MINOR) | U12767 | 8, 13.3 | 7.5, 5.7 |
MN1 | X82209 | −21, ∼−34.0 | ∼−31.6, ∼−31.4 |
Myxovirus resistance 1, homolog of murine (interferon-inducible protein p78) | M33882 | 5.2, 3.9 | 20.2, 17.4 |
Novel human gene mapping to chomosome 13, similar to rat RhoGAP | AL049801 | −3.5, ∼−15.9 | −4.9, −4 |
Nuclear factor of activated T cells, cytoplasmic, calcineurin-dependent 4 | L41066 | ∼−18.6, ∼−14.3 | ∼−8.2, ∼−10.7 |
Nuclear receptor subfamily 4, group A, member 2 | X75918 | ∼8.4, ∼9.9 | ∼9.5, ∼10.5 |
Nuclear receptor subfamily 4, group A, member 3 | U12767 | ∼23.3, ∼41.5 | ∼29.8, ∼19.0 |
Phorbol-12-myristate-13-acetate-induced protein 1 | D90070 | 9.3, 10.8 | 30.7, 25.7 |
Phosphodiesterase 4B | L20971 | −11.2, −18.8 | −3.4, −4.4 |
Pleckstrin homology, Sec7 and coiled/coil domains 1 (cytohesin 1) | M85169 | 7.7, 4.2 | 7.2, 6.7 |
Polymerase (DNA directed), gamma 2, accessory subunit | U94703 | 4.6, ∼24.3 | ∼7.6, ∼6.6 |
Protein phosphatase 1 (PPP1R5) | Y18207 | −7.6, −6.2 | −6.1, −5.3 |
RAN-binding protein 6 | AF039023 | ∼−3.8, −3.4 | −3.2, −3.9 |
ras homolog gene family, member E | S82240 | −5.9, −5.8 | −3.4, −3.6 |
ras inhibitor | L36463 | −3.5, −5.4 | −3.2, −3.6 |
RIP protein kinase | U50062 | 3, 3 | 8.5, 7.3 |
runt-related transcription factor 1 (acute myeloid leukemia 1; aml1 oncogene) | D43969 | ∼−39.3, ∼−42.2 | ∼−41.6, ∼−43.1 |
slug (chicken homolog), zinc finger protein | U69196 | −11, ∼−19.5 | −13.6, −9.2 |
Solute carrier family 7 | M80244 | 4.5, 3.7 | 4, 4.3 |
Stromal cell-derived factor 1 | L36033 | −4.2, −4.5 | −6.3, −9.7 |
Thyroid receptor interactor (TRIP14) | L40387 | 4.1, 7.4 | 61.8, 53.8 |
TR3 orphan receptor | L13740 | 6.3, 13.7 | 33.9, 26.9 |
Transcription factor 21 | AF047419 | −3.9, ∼−23.0 | −3.2, −4 |
v-myc avian myelocytomatosis viral oncogene homolog | V00568 | ∼−12.9, ∼−9.8 | ∼−12.9, −6.4 |
wee1+ (S. pombe) homolog | X62048 | −5.3, −5.3 | −4.3, −3.5 |
zinc finger protein 183 (RING finger, C3HC4 type) | X98253 | ∼−3.8, ∼−5.8 | ∼−7.9, ∼−7.5 |
zinc finger protein 217 | AF041259 | ∼−27.9, ∼−41.2 | −8, −6.6 |
Nuc ID, nucleotide sequence identification or sequence accession number.
Two fold change values were determined in independent experiments. A ∼ symbol in front of a fold change value indicates that the transcript was scored as absent in either the baseline on experimental sample and that the fold change was then calculated using the background noise value as the intensity for that comparison. The complete data set with difference calls can be accessed at http://www.molbio.princeton.edu/labs/shenk/browneetal2001/.